Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 16, 2021; 9(29): 8718-8728
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8718
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8718
Variable | GP group, (n = 24) (%) | GA group, (n = 52) (%) | P value |
Gender | 0.486 | ||
Male | 22 (91.7) | 43 (82.7) | |
Female | 2 (8.3) | 9 (17.3) | |
Age (yr) | 0.254 | ||
< 65 | 16 (66.7) | 41 (78.8) | |
≥ 65 | 8 (33.3) | 11 (21.2) | |
BMI (kg/m2) | 23.5 ± 3.5 | 23.2 ± 3.3 | 0.779 |
ASA score | 0.45 | ||
< 3 | 16 (66.7) | 39 (75.0) | |
≥ 3 | 8 (33.3) | 13 (25.0) | |
Neoadjuvant chemotherapy | < 0.001 | ||
Yes | 10 (41.7) | 44 (84.6) | |
No | 14 (58.3) | 8 (15.4) | |
Postoperative therapy | 0.199 | ||
Chemotherapy | 11 (45.8) | 32 (61.5) | |
Chemoradiotherapy | 13 (54.2) | 20 (38.5) | |
Preoperative albumin (g/L) | 37.9 ± 4.9 | 36.3 ± 5.1 | 0.083 |
Preoperative hemoglobin (g/L) | 119.0 ± 28.2 | 108.3 ± 26.5 | 0.058 |
Linitis plastica | 0.059 | ||
Yes | 1 (4.2) | 11 (21.2) | |
No | 23 (95.8) | 41 (78.8) | |
Borrmann type | 0.312 | ||
I | 1 (4.2) | 1 (1.9) | |
II | 8 (33.3) | 18 (34.6) | |
III | 14 (58.3) | 23 (44.2) | |
IV | 1 (4.2) | 10 (19.2) | |
Tumor size (cm) | 9.3 ± 2.3 | 6.7 ± 1.9 | < 0.001 |
Histological type | 0.945 | ||
Poorly differentiated | 20 (83.3) | 43 (82.7) | |
Well–moderately differentiated | 4 (16.7) | 9 (17.3) | |
Pathological N stage | 0.03 | ||
N0 | 0 (0.0) | 0 (0.0) | |
N1 | 0 (0.0) | 0 (0.0) | |
N2 | 5 (20.8) | 17 (32.7) | |
N3a | 5 (20.8) | 16 (30.8) | |
N3b | 14 (58.3) | 19 (36.5) | |
Lymphovascular invasion | 0.168 | ||
Yes | 22 (91.7) | 41 (78.8) | |
No | 2 (8.3) | 11 (21.2) | |
Neural invasion | 0.638 | ||
Yes | 17 (70.8) | 34 (65.4) | |
No | 7 (29.2) | 18 (34.6) | |
Surgical margin | < 0.001 | ||
R0 | 21 (87.5) | 0 (0.0) | |
R1 | 3 (12.5) | 52 (88.5) |
Variable | GP group, (n = 24) (%) | GA group, (n = 52) (%) | P value |
Intraoperative blood loss (mL) | 443.8 ± 104.6 | 144.2 ± 64.7 | < 0.001 |
Operation time (min) | 223.3 ± 41.6 | 192.9 ± 29.6 | 0.003 |
Postoperative hospital stay (d) | 18.2 ± 5.9 | 10 ± 3.6 | < 0.001 |
Postoperative mortality | 1 (4.2) | 2 (3.8) | 1 |
Postoperative morbidity | 8 (33.3) | 8 (15.3) | 0.128 |
Local complications | 5 (20.8) | 6 (11.5) | 0.324 |
Abdominal infection | 1 | 0 | |
Anastomotic fistula | 0 | 1 | |
Abdominal hemorrhage | 1 | 0 | |
Gastrointestinal hemorrhage | 0 | 1 | |
Disruption of wound | 1 | 0 | |
Pancreatic fistula | 2 | 3 | |
Duodenal stump fistula | 0 | 1 | |
Systemic complications | 3 (12.5) | 2 (3.8) | 0.177 |
Pulmonary infection | 1 | 0 | |
Pneumothorax | 1 | 1 | |
Renal failure | 0 | 0 | |
Diabetic ketoacidosis | 1 | 0 | |
Cardio- and cerebrovascular event | 0 | 1 | |
Clavien–Dindo classification | 0.309 | ||
II | 1 | 3 | |
IIIa | 2 | 1 | |
IIIb | 3 | 1 | |
IVa | 1 | 0 | |
IVb | 0 | 1 | |
V | 1 | 2 |
Variable | Univariate analysis | Multivariate analysis | ||
HR (95%CI) | ||||
P value | HR (95%CI) | P value | ||
Age ≥ 65/< 65 yr | 1.19 (0.567–2.505) | 0.644 | — | — |
Gender (male/female) | 1.01 (0.369–2.101) | 0.346 | — | — |
Preoperative hemoglobin < 35 g/L (yes/no) | 1.09 (0.423–3.205) | 0.524 | — | — |
Preoperative anemia | 1.18 (0.523–2.985) | 0.502 | — | — |
(hemoglobin < 90 g/L) (yes/no) | ||||
Neoadjuvant chemotherapy (yes/no) | 0.180 (0.073–0.446) | < 0.001 | 0.29 (00.103–0.821) | 0.02 |
Operation type (GP/GA) | 0.393 (0.188–0.819) | 0.013 | 0.689 (0.157–3.019) | 0.621 |
Borrmann type | 0.159 | — | — | |
I | 1 | |||
II | 1.399 (0.266–7.358) | 0.692 | ||
III | 0.479 (0.164–1.403) | 0.179 | ||
IV | 0.398 (0.144–1.100) | 0.076 | ||
Tumor diameter > 7/≤ 7 cm | 0.380 (0.190–0.758) | 0.006 | — | — |
Tumor type (linitis plastica/not) | 2.764 (1.127–6778) | 0.026 | 2.614 (1.024–6.675) | 0.033 |
Intraoperative blood loss > 400mL (yes/no) | 1.089 (0.347–2.102) | 0.154 | ||
Operation time > 240 min | 1.021 (0.233–3.112) | 0.423 | ||
Surgical margin (R0/R1) | 2.501 (1.177–5.314) | 0.017 | 0.274 (0.102–0.738) | 0.01 |
Lymphovascular invasion (yes/no) | 2.512 (1.066–5.921) | 0.035 | 1.517 (0.930–2.476) | 0.095 |
Perineural invasion (yes/no) | 1.545 (0.781–3.054) | 0.211 | — | — |
Differentiation type (poor/well–moderate) | 1.358 (0.610–3.021) | 0.454 | — | — |
N stage(N0/N1/N2/N3a/N3b) | 1.708 (1.103–2.644) | 0.016 | 3.489 (1.334–9.120) | 0.011 |
Postoperative treatment (chemotherapy/chemoradiotherapy) | 0.347 (0.159–0.757) | 0.008 | 0.369 (0.163–0.836) | 0.017 |
- Citation: Jin P, Liu H, Ma FH, Ma S, Li Y, Xiong JP, Kang WZ, Hu HT, Tian YT. Retrospective analysis of surgically treated pT4b gastric cancer with pancreatic head invasion . World J Clin Cases 2021; 9(29): 8718-8728
- URL: https://www.wjgnet.com/2307-8960/full/v9/i29/8718.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i29.8718